Skip to main content
TTrialFinderData
TrialFinderData is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Updated June 2026 · ClinicalTrials.gov

University of Florida

Reviewed by TrialFinderData Editorial Team · Updated

18 clinical trials · 18 recruiting · OTHER

University of Florida has 18 clinical trials registered on ClinicalTrials.gov, with 18 actively recruiting participants. The trials listed below cover 20 conditions across the phases listed in the sidebar. Always discuss any specific trial with your physician before contacting a study site.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About University of Florida\'s Trial Portfolio

University of Florida is a non-industry sponsor (academic medical center, hospital, foundation, or research network). Non-industry sponsors often investigate novel approaches, rare conditions, and behavioral or surgical interventions that commercial sponsors may not prioritize.

18 of University of Florida's 18 registered trials are currently recruiting — roughly 100% of the portfolio. A high recruiting share usually points to an active research pipeline with multiple programs at the enrollment stage.

University of Florida's research footprint spans Prostate Cancer (3 trials), Duchenne Muscular Dystrophy (2), and Acute Lymphoblastic Leukemia (1) as the top three conditions. The full condition list, sorted by trial count, is in the sidebar.

Not Applicable is the largest single phase in University of Florida's portfolio at 33% of registered trials. The full phase breakdown appears in the sidebar.

Trials by University of Florida

RECRUITINGNCT06465966

UFPTI 2403-PR12: Real-Time Volumetric Ionizing Radiation Acoustic Imaging for In-vivo Proton Treatment Monitoring in...

The purpose of this study is to evaluate the use of ionizing-radiation photo acoustic imaging (iRAI) for proton radiation treatment.

Sponsor: University of FloridaEnrolling: 301 location
Prostate Cancer
RECRUITINGPhase 2NCT06402357

High Intensity Focused Ultrasound in Prostate Cancer

This study will investigate the efficacy of focal high intensity focused ultrasound (HIFU) in patients with localized radiorecurrent prostate cancer. This study will also...

Sponsor: University of FloridaEnrolling: 251 location
Prostate Cancer
RECRUITINGPhase 2NCT05800210

Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases

This study will assess the safety, efficacy, and feasibility of ⍺/β CD3+ T-cell and CD19+ B-cell depletion in allogeneic stem cell transplantation in patients with acute...

Sponsor: University of FloridaEnrolling: 201 location
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaJuvenile Myelomonocytic Leukemia+4
RECRUITINGPhase 1NCT04573140

A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult...

The primary objective will be to demonstrate the manufacturing feasibility and safety, and to determine the maximum tolerated dose (MTD) of RNA-LP vaccines in (Stratum 1) adult...

Sponsor: University of FloridaEnrolling: 282 locations
Adult GlioblastomaHigh Grade GliomaWHO Grade III or IV Malignant Glioma
RECRUITINGNCT00411060

Clinical Orthopaedic Data Bank (Acute and Chronic)

Data involving orthopaedic conditions and rehabilitation aspects of musculoskeletal and neuromuscular disorders will be collected and stored as part of the normal clinical care of...

Sponsor: University of FloridaEnrolling: 100001 location
OsteoarthritisOsteosarcomaScoliosis+1
RECRUITINGNCT00811148

Florida Center for Brain Tumor Research

The purpose of this research study is to collect and store brain tumor tissue samples for future research. The samples will become part of the University of Florida Brain Tumor...

Sponsor: University of FloridaEnrolling: 40001 location
Brain Tumors
RECRUITINGPhase 1 / Phase 2NCT05000294

Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types

Checkpoint inhibitor therapy represents a significant advance in cancer care. The interaction between PD-1 and PD-L1 induces immune tolerance, and the inhibition of this...

Sponsor: University of FloridaEnrolling: 291 location
Bile Duct CancerGall Bladder CancerBreast Cancer+6
RECRUITINGNCT06911229

Neurophysiology of Locomotor Adaptation and Freezing of Gait in Parkinson's Disease

Locomotor adaptation will be studied using an established split-belt treadmill paradigm, consisting of baseline (1:1 speed ratio), split-belt adaptation (2:1) and post-adaptation...

Sponsor: University of FloridaEnrolling: 601 location
Parkinson Disease
RECRUITINGNCT05014971

Telehealth in Lewy Body Dementia

Lewy body dementia (LBD) is the 2nd most common neurodegenerative dementia in the US. Optimal care requires an interdisciplinary approach, however often faced barriers include...

Sponsor: University of FloridaEnrolling: 1061 location
Lewy Body Dementia With Behavioral DisturbanceLewy Body Parkinson DiseaseLewy Body Disease
RECRUITINGNCT07176936

Improving Speech in Noise Using Noninvasive Stimulation

Traumatic brain injury, a common injury in military service personnel, often leads to poor processing of speech in noisy environments. The goal of the current study is to better...

Sponsor: University of FloridaEnrolling: 551 location
Traumatic Brain InjuryHearing Loss
RECRUITINGPhase 4NCT05681702

Tailoring Bleeding Reduction Approaches in Patients Undergoing PCI

Two strategies have both proven to be effective in reducing bleeding complications while preserving efficacy compared with maintaining long-term DAPT with aspirin and a potent...

Sponsor: University of FloridaEnrolling: 901 location
Coronary Artery Disease
RECRUITINGNCT05580614

Paired tVNS With ERP in OCD

In the proposed investigation, the investigator will develop pilot data for the use of tVNS (transcutaneous vagal nerve stimulation) to enhance efficacy of exposure and response...

Sponsor: University of FloridaEnrolling: 561 location
OCD
RECRUITINGPhase 2NCT06455319

Precision Administration of Anti-thymocyte Globulin With or Without Verapamil

T cell directed therapy, anti-thymocyte globulin (ATG), in low doses, has been shown to lower HbA1c and preserve endogenous insulin production (measured by C-peptide) in...

Sponsor: University of FloridaEnrolling: 602 locations
Type 1 Diabetes
RECRUITINGNCT01851642

Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs

The purpose of this study is to look at how Alpha-1-antitrypsin (AAT) deficiency and Cystic Fibrosis (CF) affect white blood cells in the lungs, called macrophages, and their...

Sponsor: University of FloridaEnrolling: 2201 location
Alpha-1 Antitrypsin DeficiencyAAT DeficiencyAATD+1
RECRUITINGNCT05616130

Pathological Myeloid Activation After Sepsis and Trauma

The goal of this observational study is to better understand what happens to circulating blood after a patient experiences severe trauma injury. The main questions it aims to...

Sponsor: University of FloridaEnrolling: 2551 location
Trauma InjurySepsisImmunosuppression+1
RECRUITINGNCT04484272

A Stress and Pain Self-management m-Health App for Adult Outpatients With Sickle Cell Disease

Our long-term goal is to reduce stress and improve sickle cell disease (SCD) pain control with less opioid use through an intervention with self-management relaxation/distraction...

Sponsor: University of FloridaEnrolling: 1851 location
Sickle Cell Disease
RECRUITINGNCT01484678

Magnetic Resonance Imaging and Biomarkers for Muscular Dystrophy

The purpose of this research study is to determine the potential of magnetic resonance imaging, spectroscopy, and whole body imaging to monitor disease progression and to serve as...

Sponsor: University of FloridaEnrolling: 5503 locations
Duchenne Muscular DystrophyBecker Muscular Dystrophy
RECRUITINGPhase 2NCT06290713

Vasodilator and Exercise Study for DMD (VASO-REx)

Examining two strategies as potential adjuvant therapies for Duchenne muscular dystrophy (DMD); aerobic exercise training (to induce adaptations in skeletal muscle and improve...

Sponsor: University of FloridaEnrolling: 501 location
Duchenne Muscular DystrophyDuchenne DiseaseMuscular Dystrophy+4

How to Approach a Trial Listing

Each trial card above links to a dedicated page with the official ClinicalTrials.gov data plus a plain-English translation of the eligibility criteria. We translate technical terminology (ECOG performance status, hepatic function values, exclusionary lab thresholds) into language that a patient or caregiver can understand, but the original clinical text and the live ClinicalTrials.gov record always govern any actual eligibility decision.

Before contacting a trial site, write down questions for your treating physician using the framework on our 25 Questions guide. Discuss whether the trial fits your treatment plan, what the time commitment looks like, and whether your insurance will cover the standard-of-care portions. Trials are not a substitute for a treatment plan — they are an addition that needs medical guidance to evaluate.

Authoritative Resources

Verify any trial registration directly on ClinicalTrials.gov. For background on the FDA approval pathway that Phase 3 trials feed into, see the FDA drug approval process. For cancer-specific trial guidance, the National Cancer Institute publishes patient-oriented overviews. For global trial registrations beyond the U.S., the WHO ICTRP aggregates registries from around the world.

Frequently Asked Questions

How many clinical trials does University of Florida have on ClinicalTrials.gov?

University of Florida has 18 clinical trials registered on the federal ClinicalTrials.gov registry, of which 18 are actively recruiting participants right now. These counts come directly from the ClinicalTrials.gov API and are updated as the registry changes.

What conditions does University of Florida study?

University of Florida's registered trials cover 20 conditions on ClinicalTrials.gov, led by Prostate Cancer (3 trials), Duchenne Muscular Dystrophy (2 trials), Acute Lymphoblastic Leukemia (1 trial), Acute Myeloid Leukemia (1 trial), Juvenile Myelomonocytic Leukemia (1 trial). The complete condition list appears in the sidebar of this page; each condition links to a page listing every recruiting trial in that area, regardless of sponsor.

How do I join a University of Florida clinical trial?

Joining a clinical trial is a medical decision that should always involve your treating physician. Each trial page on this site includes the eligibility criteria translated into plain English alongside the official clinical text, plus the contact information that the sponsor has registered with ClinicalTrials.gov. Bring the trial information to your doctor before reaching out — they can review the full inclusion and exclusion criteria against your medical history and help you decide whether to pursue screening.

What does the trial phase mean?

Phase 1 trials test safety and dosing in small groups (often 20–80 healthy volunteers or patients). Phase 2 trials evaluate efficacy and side effects in larger groups (100–300 patients with the target condition). Phase 3 trials confirm efficacy and monitor safety in the largest groups (300–3,000+ patients) and form the basis of an FDA approval submission. Phase 4 studies happen after a treatment is approved, monitoring long-term safety and effectiveness in real-world use. Some trials register without a phase — common for device, behavioral, or observational studies.

Where does this trial data come from?

All trial data is pulled directly from the ClinicalTrials.gov API v2, the official federal trial registry maintained by the National Library of Medicine at NIH. Under FDAAA 801, most U.S. drug and device trials are required to register, making ClinicalTrials.gov the most comprehensive source. Sponsors are responsible for keeping their listings current; trial status can shift between data refreshes.

How This Sponsor Page Is Built

Every count on this page is derived directly from ClinicalTrials.gov API v2 records. Trial counts include all trials currently registered to this sponsor; the recruiting count reflects trials with status "Recruiting" or equivalent. Plain-English eligibility translations on each linked trial page preserve the original clinical text alongside an accessible version. Read the full methodology for the data pipeline and limitations.

Source: ClinicalTrials.gov API v2, maintained by the National Library of Medicine at NIH. Public domain. Cite as: "TrialFinderData. Data: ClinicalTrials.gov."

Medical disclaimer: This page is informational, not medical advice. Talk to your doctor about whether a clinical trial is right for you.

Last updated 2026-06-26 · 18 trials tracked for University of Florida.